Nomura Holdings
UTHR icon

Nomura Holdings’s United Therapeutics UTHR Stock Holding History

Nomura Holdings’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.4M Buy
64,800
+500
+0.8% +$249K 0.1% 135
2025
Q4 		$31.3M Sell
64,300
-50,400
-44% -$23.5M 0.04% 227
2025
Q3 		$48.1M Buy
+114,700
New +$38.6M 0.07% 166
2025
Q2 		– Sell
-15,000
Closed -$4.62M – 1967
2025
Q1 		$4.62M Buy
+15,000
New +$5.14M 0.01% 739

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Nomura Holdings's UTHR Position: Q1 2026 in Review

Nomura Holdings reduced its United Therapeutics (UTHR) stake by 55% in Q1 2026, selling an estimated $11.8M and leaving 18,984 shares worth $11.3M. The position accounts for 0.03% of the portfolio, ranked #401.

Nomura Holdings first reported a position in UTHR in Q2 2013 and has held it in 24 quarters since. The position peaked at $20.8M in Q4 2025. 850 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Nomura Holdings held 18,984 shares of United Therapeutics worth $11.3M as of Q1 2026.
  • Nomura Holdings sold 23,644 United Therapeutics shares in Q1 2026, an estimated $11.8M.
  • United Therapeutics made up 0.03% of Nomura Holdings's portfolio in Q1 2026, its #401 holding.
  • Nomura Holdings first reported a position in United Therapeutics in Q2 2013 and has held it in 24 quarters since.
  • Nomura Holdings's United Therapeutics position peaked at $20.8M in Q4 2025.
  • 850 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.